Disney Isn't Investigating Handling of Misconduct Claims, After ABC News Boss Urged Inquiry 
 

ABC News President Kim Godwin had called for an external probe of the matter last month, but a top staffer said Disney executive Peter Rice won't pursue one.

 
Former Oppenheimer Analyst Charged With Insider Trading 
 

Sergei Polevikov is accused of using his wife's personal brokerage account to buy or sell stock in advance of large pending purchases or sales by his employer, OppenheimerFunds, and allegedly netting $8.5 million in profit.

 
Darden Says Sales on Track to Outperform Pre-Pandemic Levels 
 

The Olive Garden parent sees inflation of about 4% as commodity and labor costs rise.

 
Salesforce Boosts Sales Outlook 
 

The business software provider has benefited from companies' growing reliance on cloud-based tools during the pandemic, with the spread of the Delta variant of Covid-19 prolonging that trend.

 
Dell Plans Buybacks, Provides Post-Spinoff Outlook 
 

The company estimated revenue will increase at an annual rate of 3% to 4% through the fiscal year ending in January 2026.

 
British Airways Scraps Plan for New Short-Haul Venture 
 

The airline abandoned a plan to create a new short-haul subsidiary after failing to win support from its pilots for the venture, which it had hoped would offer a way to offset pandemic-induced declines in long-haul traffic.

 
TPG Appoints New President, Makes Other Management Changes 
 

The private-equity firm is moving a group of longtime partners into leadership roles as it prepares to launch an initial public offering of its shares.

 
New Platform Backed by Fidelity, Goldman Seeks to Bring IPO Market Into Digital World 
 

Capital Markets Gateway looks to transform a business long accustomed to phone calls and pieces of paper.

 
Microsoft Keeps Surface in Its Place 
 

Microsoft's new devices come as a reporting change makes clear that hardware is but a small piece of the software giant's growing pie.

 
Big Pharma Isn't Done Rolling Out Covid Treatments 
 

Oral antiviral treatments for Covid-19 could give a public health boost and generate blockbuster sales for the drug industry.

(END) Dow Jones Newswires

September 23, 2021 15:00 ET (19:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.